(Q28269706)

English

A randomized, double-blind, placebo-controlled trial of a beta-hydroxyl beta-methyl butyrate, glutamine, and arginine mixture for the treatment of cancer cachexia (RTOG 0122)

scientific article

In more languages

Statements

scholarly article

0 references

A randomized, double-blind, placebo-controlled trial of a beta-hydroxyl beta-methyl butyrate, glutamine, and arginine mixture for the treatment of cancer cachexia (RTOG 0122) (English)

0 references

0 references

placebo-controlled trial

1 reference

based on heuristic

inferred from title

author name string

Lawrence Berk

1

0 references

Jennifer James

2

0 references

Anna Schwartz

3

0 references

Eugen Hug

4

0 references

Anand Mahadevan

5

0 references

Michael Samuels

6

0 references

Lisa Kachnic

7

0 references

language of work or name

0 references

publication date

October 2008

0 references

Supportive Care in Cancer

0 references

16

0 references

10

0 references

1179-88

0 references

Biological fate and clinical implications of arginine metabolism in tissue healing

1 reference

https://pubmed.ncbi.nlm.nih.gov/18293016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of human body composition using dual-energy x-ray absorptiometry and bioelectrical impedance analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18293016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current perspectives of catabolic mediators of cancer cachexia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18293016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Centralized assessment of dual-energy X-ray absorptiometry (DEXA) in multicenter studies of HIV-associated lipodystrophy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18293016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Attenuation of proteasome-induced proteolysis in skeletal muscle by {beta}-hydroxy-{beta}-methylbutyrate in cancer-induced muscle loss

1 reference

https://pubmed.ncbi.nlm.nih.gov/18293016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the C

1 reference

https://pubmed.ncbi.nlm.nih.gov/18293016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer chemotherapy-related symptoms: evidence to suggest a role for proinflammatory cytokines.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18293016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measurement of body fat by dual-energy X-ray absorptiometry and bioimpedance analysis in men with prostate cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18293016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of high-dose fish oil capsules for patients with cancer-related cachexia: a Cancer and Leukemia Group B study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18293016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin treatment in cancer cachexia: effects on survival, metabolism, and physical functioning.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18293016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beta-hydroxy-beta-methylbutyrate supplementation in critically ill trauma patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18293016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The randomization and stratification of patients to clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/18293016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A placebo-controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome: results from N00C1 from the North Central Cancer Treatment Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/18293016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nutritional treatment for acquired immunodeficiency virus-associated wasting using beta-hydroxy beta-methylbutyrate, glutamine, and arginine: a randomized, double-blind, placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18293016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapy insight: Cancer anorexia-cachexia syndrome--when all you can eat is yourself.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18293016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The cancer cachexia syndrome: a review of metabolic and clinical manifestations

1 reference

https://pubmed.ncbi.nlm.nih.gov/18293016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanism of the attenuation of proteolysis-inducing factor stimulated protein degradation in muscle by beta-hydroxy-beta-methylbutyrate

1 reference

https://pubmed.ncbi.nlm.nih.gov/18293016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reversal of cancer-related wasting using oral supplementation with a combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine

1 reference

https://pubmed.ncbi.nlm.nih.gov/18293016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pentoxifylline for treatment of cancer anorexia and cachexia? A randomized, double-blind, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18293016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cachexia: pathophysiology and clinical relevance

1 reference

https://pubmed.ncbi.nlm.nih.gov/18293016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18293016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systematic review of megestrol acetate in the treatment of anorexia-cachexia syndrome.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18293016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of bioelectrical impedance analysis prediction equations for body composition with the use of a multicomponent model for use in epidemiologic surveys

1 reference

https://pubmed.ncbi.nlm.nih.gov/18293016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Investigating the utility of serum cytokine measurements in a multi-institutional cancer anorexia/weight loss trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18293016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18293016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pathophysiology of wasting in the elderly

1 reference

https://pubmed.ncbi.nlm.nih.gov/18293016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18293016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00520-008-0403-7

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28269706&oldid=2177569053"